Can AI Break the “Measurement Paradigm?”

• by kffconnorg

• June 9, 2026

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

• by Kathryn Wighton

• June 5, 2026

• 4 min

Unique Digital Images as Incentives in Clinical Trials: A Digital Shift Toward Meaningful Participation

• by Xavier Tadeo, Gyula Seres, Peter Wang, Yoann Sapanel, Alexandria Remus, Jasmine L Eyal, Jason Kai-Wei Lee, Simon Chesterman, Julian Savulescu, John Eu-Li Wong, Christopher L Asplund, R Brian Stone, Benjamin C K Tee, Reza Shokri, Marlena Raczkowska, Li Ming Chong, Siong Peng Kwek, Agata Blasiak, Dean Ho

• June 8, 2026

Hereditary transthyretin amyloid cardiomyopathy caused by the rare TTR p.Ser43Asn variant in an Asian family: a case report

• by Bo Song, Youfu He, Xinghui Liu, Hui Liu, Fawang Du, Jiren Wang, Hongwen Tan, Changhai Zhang, Ping Zhang

• June 8, 2026